Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Twenty practical questions about prenatal corticosteroid therapy]

D Subtil1, L Storme, P Dufour

  • 1Service de Gynécologie-Obstétrique, Hôpital Jeanne-de-Flandre, CHRU, Lille.

Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction
|July 2, 1998
PubMed
Summary

Antenatal corticosteroids significantly reduce newborn complications and deaths. Despite proven benefits and cost-effectiveness, less than 20% of eligible premature infants receive this vital treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

What are the risk factors for severe neonatal acidosis in labor at term? A single-center retrospective case-control study.

Journal of gynecology obstetrics and human reproduction·2025
Same author

[Comparison of vaginal prostaglandins with oral misoprostol as a second line of cervical ripening after using a cervical balloon catheter].

Gynecologie, obstetrique, fertilite & senologie·2023
Same author

[Couder's maneuver. Knowledge and practices in a French university maternity hospital].

Gynecologie, obstetrique, fertilite & senologie·2022
Same author

Is the Development of Gestational Diabetes Associated With the ABO Blood Group/Rhesus Phenotype?

Frontiers in endocrinology·2022
Same author

[Ante- and postnatal growth charts in France - guidelines for clinical practice from the Collège national des gynécologues et obstétriciens français (CNGOF) and from the Société française de néonatologie (SFN)].

Gynecologie, obstetrique, fertilite & senologie·2022
Same author

Cervical maturation in breech presentation: Mechanical versus prostaglandin methods.

Journal of gynecology obstetrics and human reproduction·2022

Area of Science:

  • Obstetrics and Gynecology
  • Neonatology
  • Pharmacology

Context:

  • Corticosteroid therapy has been established for decades to reduce perinatal mortality and morbidity.
  • Despite established guidelines, current uptake of antenatal corticosteroids remains low, with less than 20% of eligible premature neonates treated.

Purpose:

  • To review the established benefits of antenatal corticosteroids in preventing adverse perinatal outcomes.
  • To highlight the discrepancy between recommended and actual clinical practice regarding corticosteroid administration.
  • To emphasize the cost-effectiveness and public health benefits of widespread antenatal corticosteroid use.

Summary:

  • Antenatal corticosteroids are proven safe and effective in reducing perinatal mortality and morbidity, even in cases of imminent delivery or rupture of membranes after 34 weeks gestation.

Related Experiment Videos

  • Despite theoretical indications for over 50% of premature neonates, current treatment rates are below 20%.
  • The study underscores the significant potential for preventing over 1,500 annual prenatal deaths in France and reducing neonatal care costs by 10% through increased antenatal corticosteroid administration.

    • Impact:

    • Increased utilization of antenatal corticosteroids could prevent a substantial number of neonatal deaths and reduce long-term healthcare costs.
    • Highlights a critical gap in obstetric care delivery, emphasizing the need for improved adherence to evidence-based guidelines.
    • Demonstrates a highly positive cost-effectiveness ratio for public health initiatives promoting antenatal corticosteroid therapy.